FindMyKOL

Anupama Shahane, MD

Basic profile

University of Pennsylvania

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionPhiladelphia, PA · NortheastSpecialtyRheumatologyFocusRheumatology/Immunology
Active KOLFindMyKOL type: RegionalLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Anupama Shahane is a Rheumatology/Immunology physician affiliated with University of Pennsylvania. OpenAlex indexes 20 publications with 622 citations (h-index 10).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
20publications

Publications indexed by OpenAlex. Counts exclude supporting files.

622citations

Citations across these publications.

10h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
5companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Amgen Inc.
    Program year20251 payment
    $118
  • AstraZeneca UK Limited
    Program year20241 payment
    $1,880
  • Janssen Scientific Affairs, LLC
    Program year20231 payment
    $73
All 5 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    50.9%
    Folate Analog Metabolic Inhibitor27.2%
    Methotrexate94%Rasuvo6%
    Part D<11 patients
    TNF inhibitor11.1%
    Enbrel25%Humira(Cf) Pen24%Humira(Cf)21%Enbrel Sureclick17%Humira Pen14%
    Part D<11 patients

    + 4 more classes in this area

  • Metabolism & gastrointestinal

    23.3%
    Corticosteroid21.5%
    Prednisone100%
    Part D≥58 patients
    Antidiarrheal microorganisms1.8%
    Folic Acid100%
    Part D<11 patients
  • Antiparasitic

    13.9%
    Antimalarial13.9%
    Hydroxychloroquine Sulfate100%
    Part D≥33 patients
Where care is delivered (Part B)69.3% facility · 30.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”